Connection

Robert Adams to Adrenergic beta-Agonists

Back to Details
This is a "connection" page, showing publications Robert Adams has written about Adrenergic beta-Agonists.
Robert Adams
Connection Strength
0.079
Adrenergic beta-Agonists
  1. Cardiovascular disease risk associated with asthma and respiratory morbidity might be mediated by short-acting beta2-agonists. J Allergy Clin Immunol. 2009 Jan; 123(1):124-130.e1.
    View in: PubMed
    Score: 0.079
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.